FASENRA (Benralizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** BENRALIZUMAB

**Strength:** 30 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** AstraZeneca Pharmaceuticals LP

**Marketing category:** BLA (BLA761070)

**Pharmacologic class:** Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA], Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]